RVRC developed the methods for quantitative processing and analysis of digitally recorded ECGs and provides this service to pharmaceutical and device companies. The developed analytic approaches permit precise and reliable measurements of the repolarization segment that are described in the following links:
The specially designed, validated, digital-based analytic programs permit detailed repolarization analysis from electrocardiographic signals obtained on all currently available digital ECG and Holter equipment. Clients of RVRC have included major pharmaceutical and device companies. The best evidence for our past and ongoing activity is provided by the fact that our group has served as central ECG, Holter and SAECG core lab for several large NIH-sponsored studies and trials.